Gay Men's Health Crisis: Treatment Issues, Volume 7 no. 11/12 - Winter, 1993/94
Bree Scott-Hartland
The study reviewed many substances for a new class of compounds that would inhibit the Long Terminal Repeat (LTR) of HIV (LTR is believed to be critically important to turning on and maintaining HIV replication). These three compounds emerged as the most promising candidates that would inhibit the LTR.
Results suggested that topotecan was the most powerful anti-HIV compound and was well tolerated in cancer patients. Curcumin was less effective, but important because it is consumed readily in food and available to a broad range of populations. There is, however, no clear evidence, at this time, that curcumin has any real benefits other than as food coloring and flavoring. The third compound, beta-lapachone, had no human toxicity information available, but seems well tolerated in animal studies.
1. Proceedings of the National Academy of Sciences, March 1993; 90:1839- 42.
Copyright (c) 1993 - Gay Men's Health Crisis. All rights reserved. Noncommercial reproduction is encouraged.
931201
GM071110
Copyright © 1993 - Treatment Issues. Reproduced with permission. Treatment Issues is published twelve times yearly by GMHC, Inc. All rights reserved. Noncommercial reproduction is encouraged. Subscription lists are kept confidential. GMHC Treatment Issues, The Tisch Building, 119 West 24th Street, New York, NY 10011 fredg@gmhc.org http://www.gmhc.org
AEGiS is made possible through unrestricted grants from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, the National Library of Medicine, and donations from users like you. Always watch for outdated information. This article first appeared in 2003. This material is designed to support, not replace, the relationship that exists between you and your doctor.
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Copyright ©1980, 2003. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .